Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Tracey Burr, Ph.D.
Executive Director, CMC Regulatory Affairs at Ionis Pharmaceuticals
Speaker

Profile

Tracey Burr is Executive Director of CMC Regulatory Affairs at Ionis Pharmaceuticals and is responsible for Ionis’ early and late phase, as well as commercial compounds. She has 20 years of drug development and global CMC regulatory experience and has spent her career working at small to mid-size pharmaceutical and biotechnology companies. Tracey received a Ph. D. in Materials Science and Engineering from MIT, M.Sc. in Chemistry from Caltech, and BA in Chemistry from Wellesley College.

Agenda Sessions

  • Regulatory CMC Strategies and Health Authority Interactions for Oligonucleotide Programs

    08:35